Caramel color in colas may increase risk of cancer
the ONA take:
People who drink sodas that contain caramel color, a popular ingredient in dark colas, are likely exposing themselves to carcinogens that contribute to development of cancer, according to a new study published in PLOS ONE.
Johns Hopkins researchers led by Keeve Nachman, PhD, at the Center for a Livable Future (CLF) conducted a follow-up study to a 2014 Consumer Reports that analyzed 11 different soft drinks for 4-methylimidazole (4-MEI) concentrations, a possible human carcinogen that is formed during the manufacture of caramel color.
They modeled exposure to 4-MEI as related to routine soft drink consumption levels in the U.S. The study also paired results with beverage consumption data from the National Health and Nutrition Examination Survey (NHANES) to measure for population risk and cancer burden.
They found that 4-MEI levels varied substantially across soda brands, even for the same type of beverage. Additionally, they found a geographic difference in 4-MEI levels, with soft drinks products sold in California containing lower levels than samples observed outside the state.
There is currently no federal limit on 4-MEI in food or beverages. However, Consumer reports petitioned the FDA to urge beverage makers in taking steps to protect public health.
“This new analysis underscores our belief that people consume significant amounts of soda that unnecessarily elevate their risk of cancer over the course of a lifetime,” said Urvashi Rangan, PhD, executive director at the Consumer Reports Food Safety and Sustainability Center.
People who drink sodas that contain caramel color are likely exposing themselves to carcinogens that contribute to development of cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|